drugset / Trial / NCT03223883
Curcumin and Vascular and Cognitive Function in Patients With Chronic Kidney Disease
Phase 2
Completed
94 enrolled
Diana Jalal
Stanford University · collabUniversity of Colorado, Boulder · collabUniversity of Colorado, Denver · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The proposed research is clinical study evaluating the therapeutic benefits of curcumin on vascular function in patients with chronic kidney disease (CKD). The study aims to establish that curcumin will improve endothelial function and reduce large artery stiffness by reducing oxidative stress and in conjunction with lowering markers of inflammation and oxidative stress. In addition, the study will evaluate the potential benefit of curcumin on cognitive function in patients with CKD.
Timeline
- Start
- 2018-06-01
- Primary completion
- 2023-01-25
- Completion
- 2023-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Curcumin | Small molecule | 2000 mg | Oral |